Atrial fibrillation and efficacy of semaglutide 2.4 mg in obesity-related HFpEF: A Patient Level Pooled analysis of STEP-HFpEF and STEP-HFpEF DM trials
30 August 2024
ESC Premium Access
Inflammation in obesity-related HFpEF: the STEP-HFpEF programme
30 August 2024
ESC Premium Access
Obesity as a risk factor for heart failure and impact on outcomes